Global Pneumococcal Bacteria Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pneumococcal Bacteria Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Pneumococcal Bacteria Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Pneumococcal Bacteria Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Pneumococcal Bacteria Vaccine Segment by Type

2.2.1 PPSV 23

2.2.2 PCV 13

2.2.3 PCV 10

2.3 Pneumococcal Bacteria Vaccine Sales by Type

2.3.1 Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Pneumococcal Bacteria Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Pneumococcal Bacteria Vaccine Sale Price by Type (2017-2022)

2.4 Pneumococcal Bacteria Vaccine Segment by Application

2.4.1 Infant

2.4.2 Children

2.4.3 Adult

2.5 Pneumococcal Bacteria Vaccine Sales by Application

2.5.1 Global Pneumococcal Bacteria Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Pneumococcal Bacteria Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Pneumococcal Bacteria Vaccine Sale Price by Application (2017-2022)

3 Global Pneumococcal Bacteria Vaccine by Company

3.1 Global Pneumococcal Bacteria Vaccine Breakdown Data by Company

3.1.1 Global Pneumococcal Bacteria Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Pneumococcal Bacteria Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Pneumococcal Bacteria Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Pneumococcal Bacteria Vaccine Revenue by Company (2020-2022)

3.2.2 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Pneumococcal Bacteria Vaccine Sale Price by Company

3.4 Key Manufacturers Pneumococcal Bacteria Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Pneumococcal Bacteria Vaccine Product Location Distribution

3.4.2 Players Pneumococcal Bacteria Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Pneumococcal Bacteria Vaccine by Geographic Region

4.1 World Historic Pneumococcal Bacteria Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Pneumococcal Bacteria Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Pneumococcal Bacteria Vaccine Annual Revenue by Geographic Region

4.2 World Historic Pneumococcal Bacteria Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Pneumococcal Bacteria Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Pneumococcal Bacteria Vaccine Annual Revenue by Country/Region

4.3 Americas Pneumococcal Bacteria Vaccine Sales Growth

4.4 APAC Pneumococcal Bacteria Vaccine Sales Growth

4.5 Europe Pneumococcal Bacteria Vaccine Sales Growth

4.6 Middle East & Africa Pneumococcal Bacteria Vaccine Sales Growth

5 Americas

5.1 Americas Pneumococcal Bacteria Vaccine Sales by Country

5.1.1 Americas Pneumococcal Bacteria Vaccine Sales by Country (2017-2022)

5.1.2 Americas Pneumococcal Bacteria Vaccine Revenue by Country (2017-2022)

5.2 Americas Pneumococcal Bacteria Vaccine Sales by Type

5.3 Americas Pneumococcal Bacteria Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pneumococcal Bacteria Vaccine Sales by Region

6.1.1 APAC Pneumococcal Bacteria Vaccine Sales by Region (2017-2022)

6.1.2 APAC Pneumococcal Bacteria Vaccine Revenue by Region (2017-2022)

6.2 APAC Pneumococcal Bacteria Vaccine Sales by Type

6.3 APAC Pneumococcal Bacteria Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Pneumococcal Bacteria Vaccine by Country

7.1.1 Europe Pneumococcal Bacteria Vaccine Sales by Country (2017-2022)

7.1.2 Europe Pneumococcal Bacteria Vaccine Revenue by Country (2017-2022)

7.2 Europe Pneumococcal Bacteria Vaccine Sales by Type

7.3 Europe Pneumococcal Bacteria Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pneumococcal Bacteria Vaccine by Country

8.1.1 Middle East & Africa Pneumococcal Bacteria Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Pneumococcal Bacteria Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Pneumococcal Bacteria Vaccine Sales by Type

8.3 Middle East & Africa Pneumococcal Bacteria Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Pneumococcal Bacteria Vaccine

10.3 Manufacturing Process Analysis of Pneumococcal Bacteria Vaccine

10.4 Industry Chain Structure of Pneumococcal Bacteria Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Pneumococcal Bacteria Vaccine Distributors

11.3 Pneumococcal Bacteria Vaccine Customer

12 World Forecast Review for Pneumococcal Bacteria Vaccine by Geographic Region

12.1 Global Pneumococcal Bacteria Vaccine Market Size Forecast by Region

12.1.1 Global Pneumococcal Bacteria Vaccine Forecast by Region (2023-2028)

12.1.2 Global Pneumococcal Bacteria Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Pneumococcal Bacteria Vaccine Forecast by Type

12.7 Global Pneumococcal Bacteria Vaccine Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck Pneumococcal Bacteria Vaccine Product Offered

13.1.3 Merck Pneumococcal Bacteria Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 Sanofi

13.2.1 Sanofi Company Information

13.2.2 Sanofi Pneumococcal Bacteria Vaccine Product Offered

13.2.3 Sanofi Pneumococcal Bacteria Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi Main Business Overview

13.2.5 Sanofi Latest Developments

13.3 Sinopharm

13.3.1 Sinopharm Company Information

13.3.2 Sinopharm Pneumococcal Bacteria Vaccine Product Offered

13.3.3 Sinopharm Pneumococcal Bacteria Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sinopharm Main Business Overview

13.3.5 Sinopharm Latest Developments

13.4 Pfizer

13.4.1 Pfizer Company Information

13.4.2 Pfizer Pneumococcal Bacteria Vaccine Product Offered

13.4.3 Pfizer Pneumococcal Bacteria Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Pfizer Main Business Overview

13.4.5 Pfizer Latest Developments

13.5 Walvax

13.5.1 Walvax Company Information

13.5.2 Walvax Pneumococcal Bacteria Vaccine Product Offered

13.5.3 Walvax Pneumococcal Bacteria Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Walvax Main Business Overview

13.5.5 Walvax Latest Developments

13.6 GSK

13.6.1 GSK Company Information

13.6.2 GSK Pneumococcal Bacteria Vaccine Product Offered

13.6.3 GSK Pneumococcal Bacteria Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 GSK Main Business Overview

13.6.5 GSK Latest Developments

14 Research Findings and Conclusion

Table 1. Pneumococcal Bacteria Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Pneumococcal Bacteria Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of PPSV 23

Table 4. Major Players of PCV 13

Table 5. Major Players of PCV 10

Table 6. Global Pneumococcal Bacteria Vaccine Sales by Type (2017-2022) & (K Units)

Table 7. Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2017-2022)

Table 8. Global Pneumococcal Bacteria Vaccine Revenue by Type (2017-2022) & ($ million)

Table 9. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2017-2022)

Table 10. Global Pneumococcal Bacteria Vaccine Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Pneumococcal Bacteria Vaccine Sales by Application (2017-2022) & (K Units)

Table 12. Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2017-2022)

Table 13. Global Pneumococcal Bacteria Vaccine Revenue by Application (2017-2022)

Table 14. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2017-2022)

Table 15. Global Pneumococcal Bacteria Vaccine Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Pneumococcal Bacteria Vaccine Sales by Company (2020-2022) & (K Units)

Table 17. Global Pneumococcal Bacteria Vaccine Sales Market Share by Company (2020-2022)

Table 18. Global Pneumococcal Bacteria Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Company (2020-2022)

Table 20. Global Pneumococcal Bacteria Vaccine Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Pneumococcal Bacteria Vaccine Producing Area Distribution and Sales Area

Table 22. Players Pneumococcal Bacteria Vaccine Products Offered

Table 23. Pneumococcal Bacteria Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Pneumococcal Bacteria Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Pneumococcal Bacteria Vaccine Sales Market Share Geographic Region (2017-2022)

Table 28. Global Pneumococcal Bacteria Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Pneumococcal Bacteria Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Pneumococcal Bacteria Vaccine Sales Market Share by Country/Region (2017-2022)

Table 32. Global Pneumococcal Bacteria Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Pneumococcal Bacteria Vaccine Sales by Country (2017-2022) & (K Units)

Table 35. Americas Pneumococcal Bacteria Vaccine Sales Market Share by Country (2017-2022)

Table 36. Americas Pneumococcal Bacteria Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Pneumococcal Bacteria Vaccine Revenue Market Share by Country (2017-2022)

Table 38. Americas Pneumococcal Bacteria Vaccine Sales by Type (2017-2022) & (K Units)

Table 39. Americas Pneumococcal Bacteria Vaccine Sales Market Share by Type (2017-2022)

Table 40. Americas Pneumococcal Bacteria Vaccine Sales by Application (2017-2022) & (K Units)

Table 41. Americas Pneumococcal Bacteria Vaccine Sales Market Share by Application (2017-2022)

Table 42. APAC Pneumococcal Bacteria Vaccine Sales by Region (2017-2022) & (K Units)

Table 43. APAC Pneumococcal Bacteria Vaccine Sales Market Share by Region (2017-2022)

Table 44. APAC Pneumococcal Bacteria Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2017-2022)

Table 46. APAC Pneumococcal Bacteria Vaccine Sales by Type (2017-2022) & (K Units)

Table 47. APAC Pneumococcal Bacteria Vaccine Sales Market Share by Type (2017-2022)

Table 48. APAC Pneumococcal Bacteria Vaccine Sales by Application (2017-2022) & (K Units)

Table 49. APAC Pneumococcal Bacteria Vaccine Sales Market Share by Application (2017-2022)

Table 50. Europe Pneumococcal Bacteria Vaccine Sales by Country (2017-2022) & (K Units)

Table 51. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Country (2017-2022)

Table 52. Europe Pneumococcal Bacteria Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Pneumococcal Bacteria Vaccine Revenue Market Share by Country (2017-2022)

Table 54. Europe Pneumococcal Bacteria Vaccine Sales by Type (2017-2022) & (K Units)

Table 55. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Type (2017-2022)

Table 56. Europe Pneumococcal Bacteria Vaccine Sales by Application (2017-2022) & (K Units)

Table 57. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Pneumococcal Bacteria Vaccine Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Pneumococcal Bacteria Vaccine Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Pneumococcal Bacteria Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Pneumococcal Bacteria Vaccine Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Pneumococcal Bacteria Vaccine Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Pneumococcal Bacteria Vaccine Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Pneumococcal Bacteria Vaccine Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Pneumococcal Bacteria Vaccine Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Pneumococcal Bacteria Vaccine

Table 67. Key Market Challenges & Risks of Pneumococcal Bacteria Vaccine

Table 68. Key Industry Trends of Pneumococcal Bacteria Vaccine

Table 69. Pneumococcal Bacteria Vaccine Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Pneumococcal Bacteria Vaccine Distributors List

Table 72. Pneumococcal Bacteria Vaccine Customer List

Table 73. Global Pneumococcal Bacteria Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Pneumococcal Bacteria Vaccine Sales Market Forecast by Region

Table 75. Global Pneumococcal Bacteria Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Pneumococcal Bacteria Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Pneumococcal Bacteria Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Pneumococcal Bacteria Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Pneumococcal Bacteria Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Pneumococcal Bacteria Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Pneumococcal Bacteria Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Pneumococcal Bacteria Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Pneumococcal Bacteria Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Pneumococcal Bacteria Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Pneumococcal Bacteria Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Pneumococcal Bacteria Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Pneumococcal Bacteria Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Pneumococcal Bacteria Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Pneumococcal Bacteria Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Pneumococcal Bacteria Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Pneumococcal Bacteria Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Pneumococcal Bacteria Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 93. Merck Basic Information, Pneumococcal Bacteria Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 94. Merck Pneumococcal Bacteria Vaccine Product Offered

Table 95. Merck Pneumococcal Bacteria Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Merck Main Business

Table 97. Merck Latest Developments

Table 98. Sanofi Basic Information, Pneumococcal Bacteria Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 99. Sanofi Pneumococcal Bacteria Vaccine Product Offered

Table 100. Sanofi Pneumococcal Bacteria Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Sanofi Main Business

Table 102. Sanofi Latest Developments

Table 103. Sinopharm Basic Information, Pneumococcal Bacteria Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 104. Sinopharm Pneumococcal Bacteria Vaccine Product Offered

Table 105. Sinopharm Pneumococcal Bacteria Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Sinopharm Main Business

Table 107. Sinopharm Latest Developments

Table 108. Pfizer Basic Information, Pneumococcal Bacteria Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 109. Pfizer Pneumococcal Bacteria Vaccine Product Offered

Table 110. Pfizer Pneumococcal Bacteria Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Pfizer Main Business

Table 112. Pfizer Latest Developments

Table 113. Walvax Basic Information, Pneumococcal Bacteria Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 114. Walvax Pneumococcal Bacteria Vaccine Product Offered

Table 115. Walvax Pneumococcal Bacteria Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Walvax Main Business

Table 117. Walvax Latest Developments

Table 118. GSK Basic Information, Pneumococcal Bacteria Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 119. GSK Pneumococcal Bacteria Vaccine Product Offered

Table 120. GSK Pneumococcal Bacteria Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. GSK Main Business

Table 122. GSK Latest Developments

List of Figures

Figure 1. Picture of Pneumococcal Bacteria Vaccine

Figure 2. Pneumococcal Bacteria Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Pneumococcal Bacteria Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Pneumococcal Bacteria Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Pneumococcal Bacteria Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of PPSV 23

Figure 10. Product Picture of PCV 13

Figure 11. Product Picture of PCV 10

Figure 12. Global Pneumococcal Bacteria Vaccine Sales Market Share by Type in 2021

Figure 13. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2017-2022)

Figure 14. Pneumococcal Bacteria Vaccine Consumed in Infant

Figure 15. Global Pneumococcal Bacteria Vaccine Market: Infant (2017-2022) & (K Units)

Figure 16. Pneumococcal Bacteria Vaccine Consumed in Children

Figure 17. Global Pneumococcal Bacteria Vaccine Market: Children (2017-2022) & (K Units)

Figure 18. Pneumococcal Bacteria Vaccine Consumed in Adult

Figure 19. Global Pneumococcal Bacteria Vaccine Market: Adult (2017-2022) & (K Units)

Figure 20. Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2017-2022)

Figure 21. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application in 2021

Figure 22. Pneumococcal Bacteria Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Company in 2021

Figure 24. Global Pneumococcal Bacteria Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Geographic Region in 2021

Figure 26. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2017-2022)

Figure 27. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Country/Region in 2021

Figure 28. Americas Pneumococcal Bacteria Vaccine Sales 2017-2022 (K Units)

Figure 29. Americas Pneumococcal Bacteria Vaccine Revenue 2017-2022 ($ Millions)

Figure 30. APAC Pneumococcal Bacteria Vaccine Sales 2017-2022 (K Units)

Figure 31. APAC Pneumococcal Bacteria Vaccine Revenue 2017-2022 ($ Millions)

Figure 32. Europe Pneumococcal Bacteria Vaccine Sales 2017-2022 (K Units)

Figure 33. Europe Pneumococcal Bacteria Vaccine Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Pneumococcal Bacteria Vaccine Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Pneumococcal Bacteria Vaccine Revenue 2017-2022 ($ Millions)

Figure 36. Americas Pneumococcal Bacteria Vaccine Sales Market Share by Country in 2021

Figure 37. Americas Pneumococcal Bacteria Vaccine Revenue Market Share by Country in 2021

Figure 38. United States Pneumococcal Bacteria Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Pneumococcal Bacteria Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Pneumococcal Bacteria Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Pneumococcal Bacteria Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Pneumococcal Bacteria Vaccine Sales Market Share by Region in 2021

Figure 43. APAC Pneumococcal Bacteria Vaccine Revenue Market Share by Regions in 2021

Figure 44. China Pneumococcal Bacteria Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Pneumococcal Bacteria Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Pneumococcal Bacteria Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Pneumococcal Bacteria Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Pneumococcal Bacteria Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Pneumococcal Bacteria Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Country in 2021

Figure 51. Europe Pneumococcal Bacteria Vaccine Revenue Market Share by Country in 2021

Figure 52. Germany Pneumococcal Bacteria Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Pneumococcal Bacteria Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Pneumococcal Bacteria Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Pneumococcal Bacteria Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Pneumococcal Bacteria Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Pneumococcal Bacteria Vaccine Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Pneumococcal Bacteria Vaccine Revenue Market Share by Country in 2021

Figure 59. Egypt Pneumococcal Bacteria Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Pneumococcal Bacteria Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Pneumococcal Bacteria Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Pneumococcal Bacteria Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Pneumococcal Bacteria Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Pneumococcal Bacteria Vaccine in 2021

Figure 65. Manufacturing Process Analysis of Pneumococcal Bacteria Vaccine

Figure 66. Industry Chain Structure of Pneumococcal Bacteria Vaccine

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles